FOXP3+ regulatory T cells: control of FOXP3 expression by pharmacological agents.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  TIPS - Trends in Pharmacological Sciences

• Publication date

  2011-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.tips.2010.12.004PMID 21237521
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate

  2010cited by this paper
• Overcoming immunological tolerance to melanoma: Targeting CTLA‐4

  2010cited by this paper
• Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders

  2010cited by this paper
• FOXP3+ regulatory T cells in the human immune system

  2010cited by this paper
• Recent advancement in nonsteroidal aromatase inhibitors for treatment of estrogen-dependent breast cancer.

  2010cited by this paper
• Updates of mTOR inhibitors.

  2010cited by this paper
• The mammalian target of rapamycin: linking T cell differentiation, function, and metabolism.

  2010cited by this paper
• Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor?

  2009cited by this paper
• Impact of the TCR Signal on Regulatory T Cell Homeostasis, Function, and Trafficking

  2009cited by this paper
• Regulatory T cells: how do they suppress immune responses?

  2009cited by this paper
• The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment.

  2009cited by this paper
• Mechanisms of foxp3+ T regulatory cell-mediated suppression.

  2009cited by this paper
• Immunomodulation of FOXP3+ Regulatory T Cells by the Aromatase Inhibitor Letrozole in Breast Cancer Patients

  2009cited by this paper
• Immunomodulatory drug FTY720 induces regulatory CD4+CD25+ T cells in vitro

  2009cited by this paper
• The AKT–mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells

  2008cited by this paper
• Detailed analysis of immunologic effects of the cytotoxic T lymphocyte-associated antigen 4-blocking monoclonal antibody tremelimumab in peripheral blood of patients with melanoma

  2008cited by this paper
• CTLA-4 Control over Foxp3+ Regulatory T Cell Function

  2008cited by this paper
• Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines.

  2008cited by this paper
• Clinical and molecular profile of a new series of patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: inconsistent correlation between forkhead box protein 3 expression and disease severity.

  2008cited by this paper
• How regulatory T cells work

  2008cited by this paper
• Regulatory T cell-resistant CD8+ T cells induced by glucocorticoid-induced tumor necrosis factor receptor signaling.

  2008cited by this paper
• Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer

  2008cited by this paper
• Regulatory T cells and immune tolerance.

  2008cited by this paper
• Rapamycin Monotherapy in Patients With Type 1 Diabetes Modifies CD4+CD25+FOXP3+ Regulatory T-Cells

  2008cited by this paper
• The Foxp3+ regulatory T cell: a jack of all trades, master of regulation

  2008cited by this paper
• Partial Reduction of Human FOXP3+ CD4 T Cells In Vivo After CD25-directed Recombinant Immunotoxin Administration

  2008cited by this paper
• De novo induction of antigen‐specific CD4+CD25+Foxp3+ regulatory T cells in vivo following systemic antigen administration accompanied by blockade of mTOR

  2008cited by this paper
• Notch1 and TGFbeta1 cooperatively regulate Foxp3 expression and the maintenance of peripheral regulatory T cells.

  2008cited by this paper
• STAT5-signaling cytokines regulate the expression of FOXP3 in CD4+CD25+ regulatory T cells and CD4+CD25- effector T cells.

  2008cited by this paper
• OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejection

  2008cited by this paper
• Cyclic adenosine monophosphate is a key component of regulatory T cell–mediated suppression

  2007cited by this paper
• Foxp3-dependent programme of regulatory T-cell differentiation

  2007cited by this paper
• IL-10-producing type 1 regulatory T cells and allergy.

  2007cited by this paper
• Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance.

  2007cited by this paper
• FOXP3: Not just for regulatory T cells anymore

  2007cited by this paper
• The inhibitory cytokine IL-35 contributes to regulatory T-cell function

  2007cited by this paper
• Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid

  2007cited by this paper
• All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation

  2007cited by this paper
• Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype.

  2007cited by this paper
• CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation–mediated apoptosis of effector CD4+ T cells

  2007cited by this paper
• Interleukin-2 administration alters the CD4+FOXP3+ T-cell pool and tumor trafficking in patients with ovarian carcinoma.

  2007cited by this paper
• Epigenetic Control of the foxp3 Locus in Regulatory T Cells

  2007cited by this paper
• Regulatory T cells and cancer.

  2007cited by this paper
• Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production.

  2007cited by this paper
• Transient regulatory T-cells: a state attained by all activated human T-cells.

  2007cited by this paper
• Regulatory T cells – a brief history and perspective

  2007cited by this paper
• DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3+ conventional T cells

  2007cited by this paper
• Reciprocal TH17 and Regulatory T Cell Differentiation Mediated by Retinoic Acid

  2007cited by this paper
• Regulatory T cell development in the absence of functional Foxp3

  2007cited by this paper
• Rapamycin inhibits differentiation of Th17 cells and promotes generation of FoxP3+ T regulatory cells.

  2007cited by this paper
• Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature.

  2007cited by this paper
• Vitamin A Metabolites Induce Gut-Homing FoxP3+ Regulatory T Cells1

  2007cited by this paper
• Control of immune responses by antigen-specific regulatory T cells expressing the folate receptor.

  2007cited by this paper
• Glucocorticoid-Induced TNF Receptor Family Related Gene Activation Overcomes Tolerance/Ignorance to Melanoma Differentiation Antigens and Enhances Antitumor Immunity1

  2006cited by this paper
• Oestradiol potentiates the suppressive function of human CD4+ CD25+ regulatory T cells by promoting their proliferation

  2006cited by this paper
• Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse.

  2006cited by this paper
• Rapamycin-Mediated Enrichment of T Cells with Regulatory Activity in Stimulated CD4+ T Cell Cultures Is Not Due to the Selective Expansion of Naturally Occurring Regulatory T Cells but to the Induction of Regulatory Functions in Conventional CD4+ T Cells1

  2006cited by this paper
• Estrogen‐mediated immunomodulation involves reduced activation of effector T cells, potentiation of treg cells, and enhanced expression of the PD‐1 costimulatory pathway

  2006cited by this paper
• FOXP3 controls regulatory T cell function through cooperation with NFAT.

  2006cited by this paper
• Cytotoxic T lymphocyte antigen‐4‐dependent down‐modulation of costimulatory molecules on dendritic cells in CD4+ CD25+ regulatory T‐cell‐mediated suppression

  2006cited by this paper
• Agonist anti-GITR antibody enhances vaccine-induced CD8(+) T-cell responses and tumor immunity.

  2006cited by this paper
• Foxp3-dependent and -independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis.

  2006cited by this paper
• Infectious tolerance and the long‐term acceptance of transplanted tissue

  2006cited by this paper
• The GITR–GITRL interaction: co-stimulation or contrasuppression of regulatory activity?

  2006cited by this paper
• Rapamycin Promotes Expansion of Functional CD4+CD25+FOXP3+ Regulatory T Cells of Both Healthy Subjects and Type 1 Diabetic Patients1

  2006cited by this paper
• The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs.

  2005cited by this paper
• Natural regulatory T cells in infectious disease

  2005cited by this paper
• Cutting Edge: Contact-Mediated Suppression by CD4+CD25+ Regulatory Cells Involves a Granzyme B-Dependent, Perforin-Independent Mechanism1

  2005cited by this paper
• Triggering of OX40 (CD134) on CD4(+)CD25+ T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR.

  2005cited by this paper
• FOXP3 acts as a rheostat of the immune response

  2005cited by this paper
• Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells

  2005cited by this paper
• CD4+ CD25+ regulatory T cells control the induction of antigen-specific CD4+ helper T cell responses in cancer patients.

  2005cited by this paper
• Autoreactive T Cells in Healthy Individuals1

  2004cited by this paper
• Antigen-specific regulatory T cells--their induction and role in infection.

  2004cited by this paper
• Supporting Online Material

  2003cited by this paper
• An essential role for Scurfin in CD4+CD25+ T regulatory cells

  2003cited by this paper
• Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

  2003cited by this paper
• CTLA-4–Ig regulates tryptophan catabolism in vivo

  2002cited by this paper
• Control of intestinal inflammation by regulatory T cells

  2001cited by this paper
• Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse

  2001cited by this paper
• The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3

  2001cited by this paper
• Immunologic Self-Tolerance Maintained by Cd25+Cd4+Regulatory T Cells Constitutively Expressing Cytotoxic T Lymphocyte–Associated Antigen 4

  2000cited by this paper
• Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity.

  1999cited by this paper
• CD28/B7 costimulation: a review.

  1998cited by this paper
• CD4+CD25+ Immunoregulatory T Cells Suppress Polyclonal T Cell Activation In Vitro by Inhibiting Interleukin 2 Production

  1998cited by this paper
• Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state.

  1998cited by this paper

• IL-2/IL-2Ab Complexes Expand Regulatory T Cells In Vivo and Provide Neuroprotection After Cardiac Arrest.

  2025cites this paper
• Neutrophils induce effective antibody responses to the pneumococcal conjugate vaccine by inhibiting regulatory T cells

  2025cites this paper
• Association between rs3761548 polymorphism of FOXP3 and the risk of gastric cancer: a case-control study

  2024cites this paper
• Differential roles of regulatory T cells in acute respiratory infections

  2023cites this paper
• The microsomal prostaglandin E synthase-1/PGE2 axis induces recovery from ischemia via recruitment of regulatory T cells.

  2022cites this paper
• Distepharinamide, a novel dimeric proaporphine alkaloid from Diploclisia glaucescens, inhibits the differentiation and proliferative expansion of CD4+Foxp3+ regulatory T cells.

  2022cites this paper
• Juzentaihoto Exerts Anti-Allergic Effects by Inhibiting Effector T-Cell Activation and Inducing and/or Activating Regulatory T Cells in a Murine Model of Contact Hypersensitivity

  2021cites this paper
• Th17/Treg imbalance in COPD development: suppressors of cytokine signaling and signal transducers and activators of transcription proteins

  2020cites this paper
• Differences in T regulatory cells between mouse strains frequently used in immunological research: Treg cell quantities and subpopulations in NOD, B6 and BALB/c mice.

  2020cites this paper
• Autoimmunity as a target for chimeric immune receptor therapy: A new vision to therapeutic potential.

  2019cites this paper
• Expression of thyroglobulin by regulatory T cells in Thyroid tissue.

  2019cites this paper
• Altered gut microbiome promotes proteinuria in mice induced by Adriamycin

  2018cites this paper
• Enhanced Suppressive Activity of Regulatory T Cells in the Microenvironment of Malignant Pleural Effusions

  2018cites this paper
• Oxygen-dependent regulation of immune checkpoint mechanisms

  2018cites this paper
• Leveraging the IncuCyte Technology for Higher-Throughput and Automated Chemotaxis Assays for Target Validation and Compound Characterization

  2018cites this paper
• Th17/Treg immunoregulation and implications in treatment of sulfur mustard gas-induced lung diseases

  2017cites this paper
• Prostaglandin E2 restrains human Treg cell differentiation via E prostanoid receptor 2-protein kinase A signaling.

  2017cites this paper
• A single neonatal administration of Bisphenol A induces higher tumour weight associated to changes in tumour microenvironment in the adulthood

  2017cites this paper
• The Yin and Yang of regulatory T cells in infectious diseases and avenues to target them

  2017cites this paper
• Inducing and Administering Tregs to Treat Human Disease

  2016cites this paper
• Reference Values for a Panel of Cytokinergic and Regulatory Lymphocyte Subpopulations

  2016influential citation
• T reg Cells A Case

  2016cites this paper
• Missed, Not Missing: Phylogenomic Evidence for the Existence of Avian FoxP3

  2016cites this paper
• Treatment with anti‐OX40L or anti‐TSLP does not alter the frequency of T regulatory cells in allergic asthmatics

  2015cites this paper
• The Biology of Regulatory T Cells in Human Allergen-Induced Asthma

  2015cites this paper
• Origin and functions of pro-inflammatory cytokine producing Foxp3+ regulatory T cells.

  2015cites this paper
• Nanomedicine and cancer immunotherapy – targeting immunosuppressive cells

  2015cites this paper
• GITR+ regulatory T cells in the treatment of autoimmune diseases.

  2015cites this paper
• The biological role of Treg cells in ectopic endometrium homeostasis.

  2014cites this paper
• The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients

  2014cites this paper
• Regulation of regulatory T cells: epigenetics and plasticity.

  2014cites this paper
• Interleukin‐17 Facilitates the Immune Suppressor Capacity of High‐Grade Glioma‐Derived CD4 (+) CD25 (+) Foxp3 (+) T Cells Via Releasing Transforming Growth Factor Beta

  2014cites this paper
• A novel Pseudolaric acid B derivative, Hexahydropseudolaric acid B, exterts an immunomodulatory effect in vitro/in vivo evaluation.

  2014cites this paper
• LPS Nephropathy in Mice Is Ameliorated by IL-2 Independently of Regulatory T Cells Activity

  2014cites this paper
• In vitro generation of human FOXP3+ regulatory T cells

  2014cites this paper
• Cell‐Based Biologic Therapy for the Treatment of Medical Diseases

  2014cites this paper
• Treg‐enriched CD4+ T cells attenuate collagen synthesis in keloid fibroblasts

  2014cites this paper
• Deficient or abundant but unable to fight? Estimation of circulating FoxP3+ T regulatory cells and their counteracting FoxP3− in rheumatoid arthritis and correlation with disease activity

  2013cites this paper
• TRAF6 Is Essential for Maintenance of Regulatory T Cells That Suppress Th2 Type Autoimmunity

  2013cites this paper
• Systematic evaluation of 640 FDA drugs for their effect on CD4⁺Foxp3⁺ regulatory T cells using a novel cell-based high throughput screening assay.

  2013cites this paper
• IL-2/anti-IL-2 complex: a novel strategy of in vivo regulatory T cell expansion in renal injury.

  2013cites this paper
• Administration of anti-CD25 mAb leads to impaired α-galactosylceramide-mediated induction of IFN-γ production in a murine model.

  2013cites this paper
• Signaling through C 5 a receptor and C 3 a receptor diminishes function of murine natural regulatory T cells

  2013cites this paper
• CD4 blockade directly inhibits mouse and human CD4(+) T cell functions independent of Foxp3(+) Tregs.

  2013cites this paper
• Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells

  2013cites this paper
• Tumor-infiltrating lymphocytes predict response to chemotherapy in patients with advance non-small cell lung cancer

  2012cites this paper
• Immunomodulation and anti-inflammatory roles of polyphenols as anticancer agents.

  2012cites this paper
• Treg Cells in Cancer: A Case of Multiple Personality Disorder

  2012cites this paper
• Regulatory T-Cells: Diverse Phenotypes Integral to Immune Homeostasis and Suppression

  2012cites this paper
• Regulatory T cells: banned cells for decades.

  2012cites this paper
• Chemokine axis as a therapeutic target to enhance the recruitment of Tregs and treat organ-specific autoimmune and inflammatory diseases.

  2012cites this paper
• Does the PI3K pathway promote or antagonize regulatory T cell development and function?

  2012cites this paper
• IL-2/IL-2Ab complexes induce regulatory T cell expansion and protect against proteinuric CKD.

  2012cites this paper
• Aspirin and immune system.

  2012cites this paper
• Immune intervention with T regulatory cells: past lessons and future perspectives for type 1 diabetes.

  2011cites this paper
• Lysophosphatidylcholine enhances the suppressive function of human naturally occurring regulatory T cells through TGF-β production.

  2011cites this paper
• Harnessing regulatory T cells for transplant tolerance in the clinic through mTOR inhibition: myth or reality?

  2011cites this paper
• Is there a potential immune dysfunction with anabolic androgenic steroid use?: A review.

  2011cites this paper
• Biomarqueurs des états septiques sévères : vers de nouvelles stratégies thérapeutiques individualisées

  2011cites this paper